July 6, 2016 – MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V – “RLV”) (Frankfurt: “6BX”) (the “Company” or “Relevium”) in conjunction with Maestro Capital Inc. (TSX.P – “MCP”) (the “CPC” or “Maestro”) is pleased to announce that the two parties have agreed to the terms of participation by Maestro in a non-brokered private placement offering (the “Private Placement”).
Pursuant to the agreed terms, Maestro will subscribe by way of subscription agreement for a minimum of 1,500,000 units (the “Units”) of Relevium at a per Unit price of $0.10 for gross proceeds of $150,000. Each unit will consist of one common share in the capital of Relevium (a “Relevium Share”) and one common share purchase warrant, each whole warrant (a “Warrant”) will entitle Maestro to purchase one common share in the capital of Relevium at a per share price of $0.15 for a period of 36 months from the date of closing of the Private Placement.
Completion of the proposed Transaction is subject to a number of conditions, including but not limited to, execution by the parties of a form of subscription agreement for the Private Placement, the receipt of all requisite corporate and regulatory approvals, shareholder and TSX approval. The Exchange’s acceptance of the Transaction will be conditional, among other things, on Maestro filing with the Exchange all documents in compliance with Exchange CPC Policy requirements. The proposed Transaction cannot close until the required approvals are obtained. There can be no assurance that the Transaction will be completed as proposed or at all.
Relevium also announced its intention to extend the private placement for a minimum of 5,000,000 Units and a maximum of 10,000,000 under the same terms, which may close in one or more tranches, for total gross proceeds of between $500,000 and $1,000,000. All securities issued by Relevium in connection with the Private Placement will be subject to a statutory hold period of four months plus one day from the date of issuance of the securities in accordance with applicable securities legislation.
Leena Lakdawala, CEO of Relevium stated: “Management is very pleased with the vote of confidence received today from Maestro Capital and its constituents. We have every intention to follow through on our current initiatives and we look forward to welcoming all of Maestro’s shareholders into Relevium”
Relevium also announced its intention to extend the expiry date of the 10,015,466 share purchase warrants issued pursuant to the August 2015 private placement closed concurrently with the completion of its Qualifying Transaction as Ovid Capital. The expiry term of the share purchase warrants will be extended for an additional term of two years and will now expiry on August 18, 2018. The extension of the warrants is subject to the regulatory approval by the TSX.
About Relevium Technologies Inc.
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium Technologies Inc. currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
CEO and Director
For additional information, please contact:
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the Company to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. There can be no assurance that the conditions to the transactions contemplated by the potential letter of intents will be satisfied or that those transactions will be completed. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.